Why Partner? - Protein Misfolding Drug Discovery Summit

Protein misfolding targeted therapeutic development is seeing an injection of scientific interest, collaborations and investment. Drug developers and researchers are scouting out the most innovative service providers with experience in:

  • Protein structure and function analysis
  • Microfluidics
  • Pre-clinical assay development for assessment of drug-target engagement
  • Preclinical model providers
  • Clinical CROs with experience of working with protein misfolding targeted therapeutics
  • Diagnostic biomarkers in patients with proteopathies

Don’t miss this unique opportunity to demonstrate your technology, experience and thought leadership to meet the increasing demands of this fast-growing field. Email sponsor@hansonwade.com to learn more.

Company Type
Seniority